PRESTIGE BIOPHARMA

COMPANY NAME

Prestige Biopharma

COMPANY TYPE

Manufacturer (Biopharmaceutical Company with manufacturing facilities)

COMPANY OVERVIEW

Prestige Biopharma is a global biopharmaceutical company primarily based out of South Korea, dedicated to the discovery, development, and manufacturing of innovative biosimilar and novel antibody therapeutics. The company actively engages in research and development to address unmet medical needs across various therapeutic areas, including oncology, immunology, and chronic diseases.

With a focus on advanced technology and scientific expertise, Prestige Biopharma operates its own state-of-the-art manufacturing facilities, allowing for the in-house production of high-quality biopharmaceutical products. Their robust pipeline consists of a range of biosimilar candidates and proprietary new drug candidates aimed at expanding access to essential medicines globally. The company strives to deliver affordable and effective treatment options to patients worldwide by leveraging its integrated capabilities from R&D to commercial manufacturing.

Prestige Biopharma manufactures and sells the following products:

* **Biosimilars:**

* HD201 (Trastuzumab biosimilar) - Tuznue®

* PBP1502 (Bevacizumab biosimilar)

* PBP1702 (Adalimumab biosimilar)

* **Antibody therapeutics:**

* PBP1510 (Anti-PAUF mAb) - For pancreatic cancer

* PBP1540 (Anti-C5a mAb) - For inflammatory diseases

* **Diagnostic Kit:**

* COVID-19 IgG/IgM Antibody Rapid Test kit